Original Research
Accepted on 22 Oct 2025
Clinical efficacy of hepatic arterial infusion chemotherapy combined with transhepatic arterial embolization plus lenvatinib and tislelizumab or transarterial chemoembolization combined with lenvatinib plus tislelizumab in the treatment of advanced hepatocellular carcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers